Protocol βΊ Changes Β· Last reviewed 2026-05-16
Changes over time
Summary
The Dutch Protocol has had several documented revisions: the case report of 1998, the formal codification by Delemarre & Cohen-Kettenis in 2006, the Endocrine Society guideline of 2009 (revised in 2017) and the Dutch Quality Standard of 2018. From 2020 various countries have introduced substantial departures from the original protocol after systematic evidence reviews.
Chronological overview
| Year | Document / event | Change |
|---|---|---|
| Before 1998 | First GnRHa treatment (Utrecht) | Clinical introduction |
| 1998 | Cohen-Kettenis & van Goozen, case report | First publication |
| 2006 | Delemarre & Cohen-Kettenis (Eur J Endocrinol) | Formalisation: Tanner-2, age 16, age 18 |
| 2009 | Endocrine Society guideline | International codification |
| 2011 | de Vries et al., first cohort (n=70) | First cohort publication |
| 2014 | de Vries et al., cohort study (n=55) | Central empirical publication |
| 2017 | Endocrine Society revision | "< 16 years" hormones possible in selected cases |
| 2018 | Quality Standard Transgender Care (NL) | National quality standard adopted (published 2019) |
| 2022 | SBU (Sweden) | Evidence insufficient to assess the effects of hormone treatment |
| 2024 | Cass Review (UK) | NHS England: puberty blockers no longer routinely available |
Main substantive changes
- 1998 β 2006: transition from case material to standardised criteria.
- 2006 β 2017: opening for cross-sex hormones under age 16 in selected cases (Endocrine Society; see WPATH SOC).
- 2017 β 2024: several countries (Sweden, Finland, UK) introduce restrictions on GnRHa outside research settings, and in 2023 the Norwegian commission Ukom recommends classifying such treatment as experimental (source).
Critical note
Several changes in this overview widened the scope of the protocol (for example hormones before age 16 under the 2017 Endocrine Society guideline), while the evaluations from 2020 onward narrowed it. The Cass Review (2024) writes that the approach was extended to a broader group of adolescents who would not have met the inclusion criteria of the original Dutch study (source).1
See also
- Timeline (full overview): Timeline 1972βpresent
- Per primary study: 1998, 2006, 2011, 2014
- Per evaluation report: Cass, SBU, COHERE
- Worldwide status 2025: Status 2025
- People register β Cohen-Kettenis, Delemarre, de Vries, Cass.
- International comparison β policy per country in table form.
- FAQ Β· Glossary Β· For parents.
Footnotes
- Cass H. Independent review of gender identity services for children and young people: final report. NHS England; April 2024.